These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 23329079

  • 1. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S, Oliveira H, Belo L, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
    [Abstract] [Full Text] [Related]

  • 2. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2010 Dec 01; 11(6):423-32. PubMed ID: 20429617
    [Abstract] [Full Text] [Related]

  • 3. Factors associated with the length of remission of psoriasis vulgaris.
    Coimbra S, Oliveira H, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Clin Drug Investig; 2013 Nov 01; 33(11):855-60. PubMed ID: 23982521
    [Abstract] [Full Text] [Related]

  • 4. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design".
    Brazzelli V, Barbagallo T, Prestinari F, Rona C, De Silvestri A, Trevisan V, Borroni G.
    Int J Immunopathol Pharmacol; 2005 Nov 01; 18(4):755-60. PubMed ID: 16388725
    [Abstract] [Full Text] [Related]

  • 5. Systematic review of UV-based therapy for psoriasis.
    Almutawa F, Alnomair N, Wang Y, Hamzavi I, Lim HW.
    Am J Clin Dermatol; 2013 Apr 01; 14(2):87-109. PubMed ID: 23572293
    [Abstract] [Full Text] [Related]

  • 6. Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy.
    Coimbra S, Catarino C, Costa E, Oliveira H, Figueiredo A, Rocha-Pereira P, Santos-Silva A.
    Br J Dermatol; 2014 Apr 01; 170(4):939-42. PubMed ID: 24245854
    [Abstract] [Full Text] [Related]

  • 7. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A, Dicle O, Yilmaz F, Coskun M, Yilmaz E.
    Photodermatol Photoimmunol Photomed; 2008 Jun 01; 24(3):123-7. PubMed ID: 18477130
    [Abstract] [Full Text] [Related]

  • 8. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG, Sala R, Arisi M, Rossi MT, Venturini M, Ortel B.
    Br J Dermatol; 2013 Jul 01; 169(1):130-6. PubMed ID: 23834117
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E, Erbil AH, Kurumlu Z, Taştan HB, Etikan I.
    J Dermatol; 2007 Jul 01; 34(7):435-40. PubMed ID: 17584319
    [Abstract] [Full Text] [Related]

  • 10. Narrowband ultraviolet B versus psoralen plus ultraviolet A therapy for severe plaque psoriasis: an Indian perspective.
    Chauhan PS, Kaur I, Dogra S, De D, Kanwar AJ.
    Clin Exp Dermatol; 2011 Mar 01; 36(2):169-73. PubMed ID: 20545955
    [Abstract] [Full Text] [Related]

  • 11. Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks.
    Gambichler T, Tigges C, Scola N, Weber J, Skrygan M, Bechara FG, Altmeyer P, Kreuter A.
    Br J Dermatol; 2011 Jun 01; 164(6):1383-6. PubMed ID: 21466532
    [Abstract] [Full Text] [Related]

  • 12. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.
    Chen X, Yang M, Cheng Y, Liu GJ, Zhang M.
    Cochrane Database Syst Rev; 2013 Oct 23; 2013(10):CD009481. PubMed ID: 24151011
    [Abstract] [Full Text] [Related]

  • 13. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
    Karrer S, Eholzer C, Ackermann G, Landthaler M, Szeimies RM.
    Dermatology; 2001 Oct 23; 202(2):108-15. PubMed ID: 11306830
    [Abstract] [Full Text] [Related]

  • 14. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    J Eur Acad Dermatol Venereol; 2010 Jul 23; 24(7):789-96. PubMed ID: 20002653
    [Abstract] [Full Text] [Related]

  • 15. Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
    Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, Figueiredo A, Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A.
    Am J Clin Dermatol; 2012 Feb 01; 13(1):37-47. PubMed ID: 21888450
    [Abstract] [Full Text] [Related]

  • 16. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC, Jeanmougin M.
    Ann Dermatol Venereol; 2010 Jan 01; 137(1):21-31. PubMed ID: 20110064
    [Abstract] [Full Text] [Related]

  • 17. The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial.
    Boztepe G, Karaduman A, Sahin S, Hayran M, Kölemen F.
    Int J Dermatol; 2006 Mar 01; 45(3):245-50. PubMed ID: 16533223
    [Abstract] [Full Text] [Related]

  • 18. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
    Werfel T, Holiangu F, Niemann KH, Schmerling O, Lüllau F, Zedler A, Sträter HD, Niebuhr M.
    Br J Dermatol; 2015 Mar 01; 172(3):746-53. PubMed ID: 25307476
    [Abstract] [Full Text] [Related]

  • 19. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
    Karakawa M, Komine M, Takekoshi T, Sakurai N, Minatani Y, Tada Y, Saeki H, Tamaki K.
    J Dermatol; 2011 Jul 01; 38(7):655-60. PubMed ID: 21352300
    [Abstract] [Full Text] [Related]

  • 20. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TT, Hawk JL.
    Arch Dermatol; 2006 Jul 01; 142(7):836-42. PubMed ID: 16847198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.